1-8 of 8
Lin Kang
Close
Sort by
Journal Articles

Development of CD19 CAR Engineered Human Placental CD34 + -Derived Natural Killer Cells (CAR19-CYNK) As an Allogeneic Cancer Immunotherapy

Marina Gergues, Irene Raitman, Joseph Gleason, Valentina Rousseva, Shuyang He, William Van Der Touw, Qian Ye, Lin Kang, Yanliang Zhang, Chin-I Pai, Wenzhong Guo, Henry Ji, Robert Hariri, Xiaokui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2779.
https://doi.org/10.1182/blood-2021-150593
Published: 2021
Journal Articles

Human Placental CD34 + -Derived Natural Killer Cells with High Affinity and Cleavage Resistant CD16 (CYNK-101) in Combination with Daratumumab for Immunotherapy Against CD38 Expressing Hematological Malignancies

Irene Raitman, Joseph Gleason, Salvatore Rotondo, Shuyang He, Valentina Rousseva, Xuan Guo, Hemlata Rana, William van der Touw, Qian Ye, Lin Kang, Robert Hariri, Xiaokui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2773.
https://doi.org/10.1182/blood-2021-148869
Published: 2021
Journal Articles

Human Placental CD34 + -Derived Natural Killer Cells with High Affinity and Cleavage Resistant CD16 (CYNK-101) for ADCC Mediated Cancer Immunotherapy

Lin Kang, Irene Raitman, PhD, Salvatore Rotondo, MS, Joseph Gleason, MS, Shuyang He, PhD, Srinivas Somanchi, PhD, Valentina Rousseva, MS, Xuan Guo, PhD, Hemlata Rana, MS, Andrea DiFiglia, BS, Qian Ye, PhD, Tanel Mahlakõiv, PhD, William Van Der Touw, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-140536
Published: 2020
Journal Articles

Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Mediate Protection Against Influenza A Viral Infection

Shuyang He, PhD, Tanel Mahlakõiv, PhD, Joseph Gleason, MS, William Van Der Touw, Lin Kang, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-139049
Published: 2020
Journal Articles

Immune Monitoring of CD34+ Placental Cell Derived Natural Killer Cell Therapy (PNK-007) in Phase I Study of Multiple Myeloma

William Van Der Touw, Lin Kang, PhD, Joseph Dennis Tario, PhD, Bhavani Stout, Vanessa Voskinarian-Berse, Valentina Rousseva, Paul K. Wallace, MS, PhD, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4457.
https://doi.org/10.1182/blood-2019-124509
Published: 2019
Journal Articles

Stroma-Free Ex Vivo Expanded, CD34+ Cord Blood-Derived NK Cells Retain Lytic Activity After Long-Term Engraftment in NSGS Mice

Mark Wunderlich, MS, Mahesh Shrestha, MS, Lin Kang, PhD, Eric Law, MS, Vladimir Jankovic, MD, Xiaokui Zhang, PhD, Uri Herzberg, PhD, DVM, Stewart Abbot, PhD, Robert Hariri, MD, PhD, James C. Mulloy, PhD
Journal: Blood
Blood (2012) 120 (21): 580.
https://doi.org/10.1182/blood.V120.21.580.580
Published: 2012
Journal Articles

Noxa mediates p18 INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors

Jamieson Bretz, Josefina Garcia, Xiangao Huang, Lin Kang, Yang Zhang, Kai-Michael Toellner, Selina Chen-Kiang
Journal: Blood
Blood (2011) 117 (7): 2179–2188.
https://doi.org/10.1182/blood-2010-06-288027
Published: 2011
Includes: Supplemental data
Journal Articles

Loss of Cxcl12/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression

Yi-Shiuan Tzeng, Hung Li, Yuan-Lin Kang, Wen-Cheng Chen, Wei-Cheng Cheng, Dar-Ming Lai
Journal: Blood
Blood (2011) 117 (2): 429–439.
https://doi.org/10.1182/blood-2010-01-266833
Published: 2011
Includes: Supplemental data